Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
281.00
+1.00 (0.36%)
Jul 16, 2025, 12:44 PM JST
Taiko Pharmaceutical Company Description
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally.
The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation.
It manufactures and sells infection control products. Taiko Pharmaceutical Co.,Ltd. exports its products.
The company was incorporated in 1946 and is headquartered in Osaka, Japan.
Taiko Pharmaceutical Co.,Ltd.
Country | Japan |
Founded | 1946 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 214 |
CEO | Takashi Shibata |
Contact Details
Address: 1-4-1, Nishi-Honmachi Osaka, 550-0005 Japan | |
Phone | 81 6 4391 1110 |
Website | seirogan.co.jp |
Stock Details
Ticker Symbol | 4574 |
Exchange | Tokyo Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | JPY |
ISIN Number | JP3442200006 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Takashi Shibata | Chief Executive Officer |